An increase in T cells expressing ISMs—PD-1, TIM-3, CTLA-4 etc.—was detected in classical Hodgkin lymphoma (HL), several non-Hodgkin lymphomas (NHL) and MM5–8. This evidence concerns the gene CTLA4 and Hodgkins lymphoma.